Clinical trial
Kisel-10- a Prospective Randomized Double-blind Placebo Controlled Study of the Results of Intervention With Selenium and Coenzyme Q10 Combined, Regarding Effect With Emphasis on Cardiovascular Mortality and Morbidity.
NCT01443780 is registered in ClinicalTrials.gov with University Hospital, Linkoeping as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Kisel-10- a Prospective Randomized Double-blind Placebo Controlled Study of the Results of Intervention With Selenium and Coenzyme Q10 Combined, Regarding Effect With Emphasis on Cardiovascular Mortality and Morbidity.
- Lead sponsor
- University Hospital, Linkoeping
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- February 28, 2010
- Enrollment
- 443 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac function, cardiovascular mortality